Explore 3 Stock Ideas & Industry Insights Download Free Report
Curaleaf Holdings (TSX: CURA)— Key Takeaways February 2026
This analysis breaks down theFebruary 2026 surge, the macro forces driving gold equities, and whether New Gold’s recovery story is strong enough to justify a sustained rerating.
In early February 2026,TSX: TDshares edged lower by approximately0.15% on 5 February, reflecting broader volatility tied to global macro uncertainty, interest-rate expectations, and sector rotation within financials. However, these near-term fluctuations contrast sharply with TD’slong-term performance strength, highlighted by an estimated~57.8% year-over-year total return, …
As of5 February 2026, the stock isup ~2% on the day, outperforming several financial peers on the TSX, while maintaining aforward dividend yield near 3.7%and aP/E around 13.8x. That combination of income, stability, and valuation discipline is exactly what dividend-focused investors are hunting for …
Key Takeaways – Pembina Pipeline TSX: PPL – February 2026
This move was not isolated—it reflectedglobal equity weakness, collapsing precious metals prices, and a resurgent U.S. dollar, all of which disproportionately affect Canada’s resource-heavy market structure.
WELL Health Technologies Corp. (TSX:WELL) operates a diversified platform of primary healthcare clinics and delivers a range of healthcare-related services. The company’s activities span clinical operations and allied health services, electronic medical records (EMR), billing and revenue cycle management, digital health applications, cybersecurity, CRH, …
Is Kinaxis’ Stock Strength in February 2026 Signalling a Broader Canadian Tech Revival?
Key Takeaways – February 2026 Snapshot
Is Emera the low-volatility, income-focused stock many investors are overlooking?
Please wait processing your request...
You are not subscribed for this report, Want to See?
One of our sales representative will contact you soon!
Welcome to Kalkine!
Start Your 7-Days Free Trial Today!